(855) 755-4754

Call today For A Consultation

Facebook Twitter
  • Dangerous Drugs
    • Zantac Cancer
    • Metformin
    • Abilify
    • Taxotere
    • Onglyza/Kombiglyze
    • Zofran
    • Xarelto
    • Invokana
    • SSRI Birth Defects
    • Pseudotumor Cerebri
    • GranuFlo/NaturaLyte
    • Clomid
    • Actos
    • Yaz/Yasmin
    • Elmiron Vision Loss Lawsuits
  • Dangerous Devices
    • 3M Defective Earplug Lawsuits
    • Essure
    • Transvaginal mesh
    • Knee Replacement
    • Hernia Mesh
    • IVC Filter
  • Dangerous Products
    • Allergen Breast Implants
    • Talcum Powder Cancer Lawsuits
    • Juul E-Cigarette
    • Round Up
  • Cases
    • Employee Retention Credit
    • Camp Lejeune Water Contamination
    • Opioids
    • Nursing Home Neglect
    • Automaker
    • GM Recall
    • NFL Head Injury
  • Blog
  • Contact

Verticals

  • Clomid

    Recent scientific studies reveal that women who use Clomid during pregnancy face a higher risk of having a child with serious birth defects, some potentially fatal.

  • Pseudotumor cerebri

    Our attorneys here at Principal Law Group are currently investigating possible law suits on behalf of women who have used specific kinds of birth control and are now suffering from pseudotumor cerebri.

  • Invokana

    The problem with Invokana is that it can dehydrate some patients, decrease blood volume, and cause poor circulation in the body.

  • Xarelto

    Xarelto has no known antidote, meaning that it can be impossible for doctors to stop severe hemorrhaging in patients taking Xarelto.

  • Zofran

    Zofran is used alone or with other medications to prevent and treat nausea and vomiting associated with post-surgery medications or from chemotherapy and radiation therapy.

  • Onglyza/Kombiglyze

    Both Onglyza and Kombiglyze, were required to add warnings about the risk of heart failure. Additional, there are warnings about pancreatitis and pancreatic cancer

  • Taxotere

    Taxotere or Doexta is the most prescribed anti-cancer chemotherapy drug on the market due to its ability to interfere with the growth and spread of cancer cells in the body.

  • Abilify

    Even with the growing concerns over stroke risk, Abilify was marketed as a safe and effective for these disorders.

  • Actos

    The popular diabetes drug Actos (pioglitazone hydrochloride) has been linked to an increase in the risk of bladder cancer in some patients.

  • GranuFlo / NaturaLyte

    Patients who received treatment with GranuFlo and NaturaLyte have reported potentially fatal side effects such as heart attack or stroke.

  • Asbestos / Mesothelioma

    When asbestos is broken down, the fibers become airborne and can be easily inhaled and lodged in the lining of the lungs.

  • SSRI Birth Defects

    Selective serotonin reuptake inhibitors - a class of medications used to treat depression - include some popular antidepressants prescribed by healthcare professionals today.

  • Transvaginal Mesh

    Transvaginal mesh is a type of surgical mesh inserted through the vagina, commonly used to treat two conditions suffered by many women.

  • Yaz/Yasmin

    Yaz and Yasmin, a popular birth control pill that has been on the market since 2006, has been linked with a number of serious and often life-threatening complications...

(855) 755-4754

Call today For A Consultation

Blog

Principal Law Group » Blog

Johnson & Johnson Reaches Deal for $8.9 Billion Talc Settlement

Posted on April 10, 2023 by plgadmin

By Tiffany Hsu Tiffany Hsu has followed the Johnson & Johnson talc litigation closely for more than five years. April 4, 2023 Johnson & Johnson said on Tuesday that it had agreed to pay $8.9 billion to tens of thousands of...

Continue Reading →

Bayer to pay $1.6 billion to resolve U.S. claims for Essure birth-control device

Posted on August 20, 2020 by plgadmin

German drugs and pesticides group Bayer (BAYGn.DE) said on Thursday it will pay around $1.6 billion to settle the majority of U.S. claims involving its Essure birth-control device. The agreement follows a $10.9 billion settlement in June of U.S. lawsuits...

Continue Reading →

Bayer chairman quits after making progress to settle litigation

Posted on February 27, 2020 by plgadmin

FRANKFURT, Feb 26 (Reuters) – Bayer, which is fighting claims its weedkiller Roundup causes cancer, said its Chairman Werner Wenning was stepping down because the drugs and crop protection company was making good progress in settlement talks. “We have made...

Continue Reading →

Roundup Cases Going Before Juries In Multiple Courts Over Next Few Weeks

Posted on January 22, 2020 by plgadmin

As reports continue to suggest that Bayer is working to settle Roundup cases, claims involving at least six different individuals diagnosed with non-Hodgkins lymphoma following exposure to the controversial weedkiller are scheduled for trial to begin over the next week....

Continue Reading →

Bayer blames surging Roundup suits on ‘exponential increase’ in plaintiff TV ads

Posted on January 16, 2020 by plgadmin

Pharma sales growth, new drug approvals and faster-than-expected asset sales may show the bright side of today’s Bayer. But mounting Roundup lawsuits are a darker story. The number of plaintiffs claiming Bayer’s Roundup weedkiller caused cancer has snowballed to 42,700 as of...

Continue Reading →
  • Page 1 of 16
  • 1
  • 2
  • 3
  • …
  • 16

Contact Info

Principal Law Group
20 F Street NW, 7th Floor
Washington, DC, 20001
855-755-4PLG

Privacy Policy / DNC Policy

Quick Links

  • Home
  • Dangerous Drugs
  • FAQs
  • Blog
  • Contact Us
  • Site Map
Disclaimer - Thank you for your visit. The content published on this website was not written by medical professionals and should not, at any point, be mistaken for medical advice. Furthermore, the information on this site is intended for educational purposes only and should never interfere with a patient/site visitor and his or her healthcare provider. In addition, viewing the content on this website, requesting additional information, or transmitting information through a contact form should never be considered the formation of an attorney-client relationship. The material published on this site is general and may not apply to your specific circumstances. Every case comes with its own set of unique circumstances; past success discussed on this site does not guarantee future performance. Information found on this website should not be used as incentive to act without seeking counsel from a professional. For more information, please read our disclaimer. Attorney sponsoring this site is licensed in Washington DC - Principal Law Group, LLP - 20 F Street NW, 7th Floor, Washington, DC, 20001

Copyright © 2025 Principal Law Group, LLP.